For the SERS detection of cTnI together with neuropeptide Y, the latter also being a biomarker involved in myocardial infarction, Wen et al. (2020) developed a sandwich immunoassay integrated with an active microfluidic device. Here, TNNI3 is linked to myocardial infarction.